Rhumbline Advisers Oyster Point Pharma, Inc. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.6 - $11.2 $48,711 - $151,547	-13,531 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$8.58 - $17.65 $22,033 - $45,325	2,568 Added 23.42%	13,531 $158,000
Q4 2021 Feb 10, 2022	SELL	$10.17 - $18.96 $2,166 - $4,038	-213 Reduced 1.91%	10,963 $200,000
Q3 2021 Nov 12, 2021	BUY	$11.67 - $18.07 $6,126 - $9,486	525 Added 4.93%	11,176 $132,000
Q2 2021 Aug 05, 2021	BUY	$16.25 - $21.51 $173,078 - $229,103	10,651 New	10,651 $183,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.